ImprimisRx News and Activities

ImprimisRx is owned by Harrow.

Harrow is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Harrow is a company listed under the stock ticker HROW (US).

Harrow has a direct presence in 2 countries.

View the org chart displaying its 6 main executives

Most searched biographies at ImprimisRx

• Frank Mullery, Chief Executive Officer
• Scott Oppenheim, Senior Director, Supply Chain
• Rachael Malanka, Key Account Manager

Popular executive movements at ImprimisRx

• Rachael Malanka who was Pharmacy Sales Manager, becomes Key Account Manager  (posted on April 9 2026).
• John Saharek, President and Chief Executive Officer, has left the company  (posted on October 7 2025).
• Frank Mullery has joined the company as Chief Executive Officer  (posted on October 7 2025).

Click here to view some more movements at ImprimisRx

Create your alert
to follow the executive moves at ImprimisRx.

Harrow has 1,915 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• AbbVie has announced the acquisition of Apogee Therapeutics  (posted on June 23 2026).
• The new name of Stealth BioTherapeutics is Mighty Therapeutics. (posted on June 19 2026).
• Transcend has announced the acquisition of Otsuka America Pharmaceutical  (posted on June 18 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Tracey Franklin - Chief People and Digital Technology Officer at Moderna
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by ImprimisRx

Social media about ImprimisRx

• ImprimisRx on Wikipedia, Google News & Yahoo Finance
• ImprimisRx on LinkedIn, X (Twitter) & YouTube